Account Login
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Avid Bioservices Inc (NQ: CDMO )

12.49 +0.86 (+7.39%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 19, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Avid Bioservices Inc

< Previous 1 2 Next >
7 Micro-Cap Stocks to Buy and Hold for the Next 10 Years
Finding micro-cap stocks to buy requires a bit of everything, including patience. Today's plan is to pick from the top of the IWC ETF. 
Via InvestorPlace
Avid Bioservices's Return On Capital Employed Overview
Pulled from Benzinga Pro data, Avid Bioservices (NASDAQ:CDMO) showed a loss in earnings since Q2, totaling $2.25 million. Sales, on the other hand, increased by 20.68% to $31.51... 
Via Benzinga
Recap: Avid Bioservices Q3 Earnings
Avid Bioservices (NASDAQ:CDMO) reported its Q3 earnings results on Tuesday, March 8, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Avid... 
Via Benzinga
Avid Bioservices's Earnings: A Preview
Avid Bioservices (NASDAQ:CDMO) is set to give its latest quarterly earnings report on Tuesday, 2022-03-08. Here's what investors need to know before the announcement. Analysts... 
Via Benzinga
How Bad Are Avid Bioservices's Earnings? | Return On Capital Employed
According to Benzinga Pro, during Q2, Avid Bioservices (NASDAQ:CDMO) earned $4.15 million, a 40.08% increase from the preceding quarter. Avid Bioservices's sales decreased to $26.... 
Via Benzinga
Avid Bioservices, inc (CDMO) Q2 2022 Earnings Call Transcript
CDMO earnings call for the period ending October 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Earnings Scheduled For March 8, 2022
Companies Reporting Before The Bell • Babcock & Wilcox (NYSE:BW) is likely to report quarterly earnings at $0.10 per share on revenue of $196.62 million. •... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 8, 2021
Upgrades According to Deutsche Bank, the prior rating for Goodyear Tire & Rubber Co (NASD... 
Via Benzinga
Avid Bioservices: Q2 Earnings Insights
Avid Bioservices (NASDAQ:CDMO) reported its Q2 earnings results on Tuesday, December 7, 2021 at 04:05 PM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
Earnings Scheduled For December 7, 2021
Companies Reporting Before The Bell • Core & Main (NYSE:CNM) is expected to report quarterly earnings at $0.30 per share on revenue of $1.29 billion. •... 
Via Benzinga
Earnings Preview: Avid Bioservices
Avid Bioservices (NASDAQ:CDMO) is set to give its latest quarterly earnings report on Tuesday, 2021-12-07. Here's what investors need to know before the announcement. Analysts... 
Via Benzinga
7 A-Rated Biotechs to Buy for the Long Run
The one thing the pandemic has shown us is biotechs are changing the way we treat diseases. These A-rated biotechs are great examples. 
Via InvestorPlace
60 Biggest Movers From Yesterday
Gainers Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares surged 308.1% to settle at $9.59 on Tuesday after the company signed an agreement with Waas Group for the... 
Via Benzinga
Why Avid Bioservices Stock Surged 14% Today
The stock will be part of a well-known index. 
Via The Motley Fool
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Ocugen (NASDAQ:OCGN) shares increased by 26.44% to $11.81 during Tuesday's regular session. Trading volume for this security as of 12:30 EST is 135.6 million,... 
Via Benzinga
40 Stocks Moving In Tuesday's Mid-Day Session
Gainers Wallbox N.V. (NYSE: WBX) shares climbed 54.5% to $17.16. Uber and Wallbox N.V. disclosed a strategic partnership to simplify the transition to EVs for Bay Area ride... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Ocugen (NASDAQ:OCGN) stock increased by 31.15% to $12.25 during Tuesday's pre-market session. The market value of their outstanding shares is at $2.4 billion.... 
Via Benzinga
48 Biggest Movers From Yesterday
Gainers Rocket Lab USA, Inc. (NASDAQ: RKLB) jumped 37.3% to settle at $20.72. Rocket Lab reported 1H sales of $29.5 million and announced it has been awarded a contract to deploy... 
Via Benzinga
Avid Bioservices, inc (CDMO) Q1 2021 Earnings Call Transcript
CDMO earnings call for the period ending July 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Impel NeuroPharma (NASDAQ:IMPL) shares increased by 22.16% to $20.29 during Thursday's regular session. Trading volume for this security as of 12:30 EST is 1.1... 
Via Benzinga
35 Stocks Moving In Thursday's Mid-Day Session
Gainers Gevo, Inc. (NASDAQ: GEVO) shares climbed 36.6% to $7.91. Chevron and Gevo announced intent to pursue sustainable aviation fuel investment. Offerpad Solutions Inc (NYSE:... 
Via Benzinga
Earnings Scheduled For September 8, 2021
Companies Reporting Before The Bell • Nanobiotix (NASDAQ:NBTX) is likely to report earnings for its first quarter. • Waterdrop (NYSE:WDH) is expected to report... 
Via Benzinga
66 Biggest Movers From Yesterday
Gainers Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) shares jumped 50.5% to close at $20.74 on Wednesday. The company, last month, priced its IPO at $11 per share. Dyadic... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Editas Medicine Stock Shows Improved Relative Strength Rating
A Relative Strength Rating upgrade for Editas Medicine shows improving technical performance. Will it continue? 
Via Investor's Business Daily
Stocks That Hit 52-Week Highs On Tuesday
Before 10 a.m. ET on Tuesday, 100 stocks hit new 52-week highs. Things to Consider: The largest company by market cap to break to a new 52-week high was Pfizer (... 
Via Benzinga
Alnylam Pharmaceuticals Stock Sees Healthy Rising Relative Strength Rating
The Relative Strength (RS) Rating for Alnylam Pharmaceuticals stock climbed into a new percentile Monday, as it got a lift from 63 to 71. 
Via Investor's Business Daily
C4 Therapeutics Stock Enters Leadership Territory
A Relative Strength Rating upgrade for C4 Therapeutics shows improving technical performance. 
Via Investor's Business Daily
The Daily Biotech Pulse: Spero Spikes On Pfizer Investment, FDA Nod For Jazz, Orchard Signs Licensing Deal, Acumen Pharma Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 30) Ambrx Biopharma Inc. (NYSE... 
Via Benzinga
Exposures Product Safety
10 Biggest Price Target Changes For Wednesday
Wells Fargo raised the price target for Occidental Petroleum Corporation (NYSE: 
Via Benzinga
Avid Bioservices, Inc. (CDMO) Q4 2021 Earnings Call Transcript
CDMO earnings call for the period ending April 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.